Consider referring a patient with suspected neuroendocrine tumours to a specialist promptly when clinical features raise suspicion of cancer. Although the provided guideline excerpts do not specify neuroendocrine tumours explicitly, the general principle for suspected cancer referral applies: if there are symptoms or signs associated with an increased risk of cancer that meet referral criteria, or if there is diagnostic uncertainty, refer urgently using the suspected cancer pathway.
Make the referral within 1 working day once the decision to refer is made. If uncertain about the need for referral, consider contacting a specialist for advice.
Provide the patient with clear information about the referral process, what to expect, and support available.
This approach aligns with NICE guideline NG12 on suspected cancer recognition and referral, which recommends urgent referral for any suspected cancer based on clinical features and diagnostic suspicion, with specialist input if uncertain NICE NG12.